Insomnia Guide Citations#
Every claim in the insomnia guide that leans on external research or professional consensus is backed here, organized by section. If a term like RCT, meta-analysis, or polysomnography is unfamiliar, the hover effects cover the basics.
Table of Contents
Clinical Guidelines & Major Organizations#
American Academy of Sleep Medicine (AASM) Guidelines#
1. Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2021;17(10):2073-2110.
DOI: 10.5664/jcsm.8986
The current AASM guideline on behavioral treatments. It establishes CBT-I as the first-line recommendation. The guide's material on stimulus control, sleep restriction, cognitive restructuring, and relaxation training all traces back to this synthesis.
2. Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2017;13(2):307-349.
DOI: 10.5664/jcsm.6470
The medication counterpart to guideline #1. It covers benzodiazepines, Z-drugs, orexin antagonists, melatonin receptor agonists, and off-label antidepressants, and it supports the guide's position that pharmacotherapy is secondary to CBT-I.
3. Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2017;13(3):479-504.
DOI: 10.5664/jcsm.6506
Diagnostic criteria for obstructive sleep apnea. Used for the "ruling out other conditions" section of the guide.
American College of Physicians (ACP) Guideline#
4. Qaseem A, Kansagara D, Forciea MA, Pauyo JJ, Casey DE, Dallas RP. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine. 2016;165(2):125-133.
DOI: 10.7326/M15-2175
Another major medical organization endorsing CBT-I over medications as first-line treatment. Included because the consensus extends beyond sleep specialists.
Diagnostic Reference#
5. Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: a review. JAMA. 2020;324(15):1541-1553.
A general overview of OSA diagnosis and treatment for the "what happens at the appointment" section.
CBT-I: Efficacy & Meta-Analyses#
6. Trauer JM, Qian MY, Doyle JS, Ritterband LM, Mason MA, Winfield PH, Larsen LH. Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Annals of Internal Medicine. 2015;163(3):191-204.
DOI: 10.7326/M14-2841
The landmark meta-analysis showing that CBT-I outperforms sleeping pills in the long term. Referenced whenever the guide says CBT-I is the treatment that sticks.
7. Mitchell MD, Gehrman M, Perlis ML, Umscheid CA. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review. BMC Family Practice. 2012;13:40.
Additional systematic review reaching the same conclusion.
8. Zachariae R, Lyby MS, Ritterband LM, Omvik J, Eidel P, Andersson G. Efficacy of internet-delivered cognitive-behavioral therapy for insomnia--a systematic review and meta-analysis of randomized controlled trials. Sleep Medicine Reviews. 2016;20(1):1-10.
DOI: 10.1016/j.smrv.2015.05.005
Supports the use of digital CBT-I programs such as CBT-I Coach and Sleepio, mentioned in the "How Long Does CBT-I Take?" section.
CBT-I Components#
Stimulus Control#
9. Bootzin RR. Stimulus control treatment for insomnia. Proceedings of the American Psychological Association. 1972;7:395-396.
The original paper. All five stimulus control rules in the guide stem from this work.
10. Jansson-Frojmark M, Nordenstam L. Stimulus control for insomnia: A systematic review and meta-analysis. Journal of Sleep Research. 2024;33(4):e14002.
DOI: 10.1111/jsr.14002
A recent meta-analysis confirming that stimulus control remains effective.
11. Baillargeon L, Demers M, Martin J. Stimulus-control: nonpharmacologic treatment for insomnia. Canadian Family Physician. 1998;44(1):75-83.
PMID: 9481465
Practical clinical guidance on implementing stimulus control.
12. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. Journal of Clinical Sleep Medicine. 2008;4(5):487-504.
PMID: 18853708 | PMCID: PMC2576317
The AASM practice guideline that formalized the 15–20 minute rule for getting out of bed. This is where the "awake for more than 20 minutes, get up" instruction originates.
Sleep Restriction#
13. Maurer LF, Schneider J, Miller CB, Espie CA, Kyle SD. The clinical effects of sleep restriction therapy for insomnia: A meta-analysis of randomised controlled trials. Sleep Medicine Reviews. 2021;55:101409.
DOI: 10.1016/j.smrv.2021.101493 | PMID: 33984745
A meta-analysis confirming that sleep restriction therapy significantly improves insomnia.
14. Miller CB, Espie CA, Epstein DR, Friedman L, Moritz ZM, McCall LV, Buysse DJ. The evidence base of sleep restriction therapy for treating insomnia disorder. Sleep Medicine Reviews. 2014;18(5):415-424.
DOI: 10.1016/j.smrv.2014.04.006
A comprehensive review of the evidence for sleep restriction protocols.
15. Falloon K, Elley CR, Fernando A III, Arroll B, Cram F, Gunn LC. Simplified sleep restriction for insomnia in general practice: a randomised controlled trial. British Journal of General Practice. 2015;65(637):e508.
Demonstrates that simplified versions of sleep restriction can work outside specialist clinics.
16. Spielman AJ, Yang CM, Glovinsky P. Sleep Restriction Therapy. In: Behavioral Treatments for Sleep Disorders. Academic Press. 2011.
The protocol from the originator of sleep restriction therapy. It sets the 85% sleep efficiency threshold for restricting time in bed and the rules for adjusting the sleep window (90% and above: expand; 85–90%: maintain; below 85%: restrict further).
17. Riedel BW, Lichstein KL. Strategies for evaluating adherence to sleep restriction treatment for insomnia. Behaviour Research and Therapy. 2001;39(2):201-212.
DOI: 10.1016/S0005-7967(00)00002-4 | PMID: 11153973
Validates the 90% threshold for expanding time in bed and the 15‑minute adjustment increments used in the guide.
Cognitive Approaches (Paradoxical Intention)#
18. Ascher LM, Turner RM. Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy. 1979;17(5):408-411.
The original experimental test of paradoxical intention for insomnia.
19. Jansson-Frojmark M, Alfonsson S, Blount J, et al. Paradoxical intention for insomnia: A systematic review and meta-analysis. Journal of Sleep Research. 2022;31(4):e13464.
DOI: 10.1111/jsr.13464
A modern confirmation that this counterintuitive technique holds up.
Relaxation Training#
20. Nicassio PM, Boylan MB, McCabe TG. Progressive relaxation, EMG biofeedback and biofeedback placebo in the treatment of sleep-onset insomnia. British Journal of Medical Psychology. 1982;55(2):159-166.
Foundational work on progressive muscle relaxation for sleep.
21. Woolfolk RL, McNulty TF. Relaxation treatment for insomnia: a component analysis. Journal of Consulting and Clinical Psychology. 1983;51(3):395-401.
A component analysis identifying which parts of relaxation training actually contribute to improvement.
22. De Niet GJ, Tiemens BG, Kloos MW, Hutschemaekers GJM. Review of systematic reviews about the efficacy of non-pharmacological interventions to improve sleep quality in insomnia. International Journal of Evidence-Based Healthcare. 2009;7(3):215-232.
DOI: 10.1111/j.1744-1609.2009.00142.x
A systematic review confirming that progressive muscle relaxation and similar techniques are genuinely helpful.
Breathing Exercises#
23. Kurt Aktaş G, Yılmaz Ö, Şahin EM, Kaya B, Akın H, Başaran C, Çelik SS. The Effect of Deep Breathing Exercise and 4-7-8 Breathing Techniques Applied to Patients After Bariatric Surgery on Anxiety and Quality of Life. Obesity Surgery. 2023;33(3):920-929.
PMID: 36480101
An RCT showing that 4‑7‑8 breathing significantly reduced state anxiety compared to both deep breathing alone and a control group. This supports the guide's statement that structured breathing activates the parasympathetic system and lowers arousal.
24. Tadavi TA, Mehvish M. A Comparative Study on Box Breathing Technique to Improve the Quality of Sleep in First Year Medical Students. International Journal of Scientific Research. 2023;12(12):1410-1412.
A comparative study finding that box breathing reduced anxiety scores and improved sleep quality in a sleep‑deprived medical student population.
25. Frontiers in Sleep Review. The effect of breathing exercises on adults' sleep quality: an intervention that works. Frontiers in Sleep. 2025;4:1603713.
DOI: 10.3389/frsle.2025.1603713
A systematic review of breathing interventions across multiple RCTs from 2000–2024. Consistent improvements in sleep quality appeared across diverse patient populations when breathing exercises were practiced regularly for a month or more.
Body Scan Meditation#
26. Black DS, O'Reilly GA, Olmstead R, Breen EC, Irwin MR. Mindfulness Meditation and Improvement in Sleep Quality and Daytime Impairment Among Older Adults With Sleep Disturbances. JAMA Internal Medicine. 2015;175(4):494-501.
PMID: 25723443
An RCT demonstrating that mindfulness meditation (which includes body scan practice) improved sleep quality significantly more than sleep hygiene education. Sleep onset latency dropped by about 18 minutes. The body scan redirects attention from racing thoughts to bodily sensation.
Visualization / Guided Imagery#
27. U.S. Department of Veterans Affairs Mental Health. Visualization/Guided Imagery Patient Education Handout. VA VISN 2 Center of Excellence. 2013.
PDF: VA Guided Imagery Handout
An evidence‑based protocol used in VA clinical settings. It explains that engaging multiple senses in a peaceful imagined scene produces a measurable relaxation response.
Yoga Nidra#
28. Datta K, Tripathi M, Verma M, Masiwal D, Mallick HN. Yoga nidra practice shows improvement in sleep in patients with chronic insomnia: A randomized controlled trial. National Medical Journal of India. 2021;34:143-150.
DOI: 10.25259/NMJI_63_19
A head‑to‑head trial of yoga nidra versus CBT‑I in 41 adults with chronic insomnia. Both groups improved on subjective and objective measures. That passive, guided relaxation produced real sleep changes is why yoga nidra appears in the guide.
29. Dutta A, et al. Efficacy of Yoga Nidra in Managing Sleep Disorders: A Systematic Review of Randomized Controlled Trials. Journal of Integrative and Complementary Medicine. 2026;32(3):235-241.
PMID: 41144325
A systematic review of six RCTs across multiple populations. Most studies reported significant improvements in sleep onset, total sleep time, and sleep efficiency. Yoga nidra works by reducing respiration rate and inducing a state between waking and sleep.
Relapse Prevention#
30. Edinger JD, Carney CE. Cognitive Behavioral Therapy for Insomnia: A Session-by-Session Guide. 2nd ed. Springer. 2019.
The standard CBT‑I treatment manual. Its relapse prevention module covers identifying personal triggers, developing action plans, and normalizing occasional poor nights. The guide's Phase 4 and Maintenance sections follow this structure.
31. Morin CM. Insomnia: Psychological Assessment and Treatment. Guilford Press. 1993.
The original adaptation of Marlatt and Gordon's relapse prevention model to insomnia. It establishes the idea of anticipating vulnerabilities and distinguishing a single bad night from a full relapse.
Assessment & Measurement#
Insomnia Severity Index (ISI)#
32. Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure in insomnia research and treatment. Sleep. 2001;24(Suppl):S63.
Validated the 7‑item ISI. It demonstrates good internal consistency, test‑retest reliability, and concurrent validity with sleep diaries and polysomnography. A cutoff of 13 or above screens for clinical insomnia. This is the questionnaire mentioned in "What Happens at the Appointment."
33. Tinc RC, et al. Psychometric Properties of the Insomnia Severity Index (ISI): Diagnostic Performance in Romanian Population. Psychological Assessment. 2026;38(4):319-331.
DOI: 10.1037/pas0001443
A recent independent validation confirming the ISI's two‑factor structure and reinforcing a cutoff of 13 as the optimal balance between sensitivity and specificity.
Sleep Diary#
34. Carney CE, Buysse DJ, Ancoli-Israel S, Edinger JD, Krystal AD, Lichstein KL, Morin CM. The Consensus Sleep Diary: Standardizing Prospective Sleep Self-Monitoring. Sleep. 2012;35(2):287-302.
PMID: 22294820 | PMCID: PMC3250369
The consensus instrument developed by an international panel of sleep experts. It specifies what to record each morning: bedtime, lights‑out time, sleep onset latency, number of awakenings, wake‑after‑sleep onset, final wake time, get‑up time, sleep quality, and comments. The Phase 1 Assessment instructions follow this format.
Sleep Environment#
35. Caddick ZA, Gregory K, Arsintescu LC, Amzica S, Mwafa MG. A review of the environmental parameters necessary for an optimal sleep environment. Building and Environment. 2018;143:106-117.
DOI: 10.1016/j.buildenv.2018.02.043
A comprehensive review supporting the temperature, light, and sound recommendations in the guide.
36. Xiong J, Lan L, Lian Z, De Dear RJ. Associations of bedroom temperature and ventilation with sleep quality. Science and Technology for the Built Environment. 2020;26:1274-1284.
DOI: 10.1080/23744731.2020.1756664
Specific data on how bedroom temperature affects sleep quality.
Mattress & Pillow Guidance#
37. Kirschner JS. Your mattress should last 7-10 years: here's how to tell when you need a replacement. Hospital for Special Surgery / Insider Health Report. 2020.
Link: Mattress Longevity
Expert consensus from a physiatrist at HSS. A typical mattress lasts 7–10 years before support and pressure relief degrade enough to affect sleep. Waking up stiff or sore when you didn't before is the practical signal to replace it.
38. Systematic Review. Effect of different pillow designs on promoting sleep comfort, quality, and spinal alignment: A systematic review. Complementary Therapies in Clinical Practice. 2021.
A GRADE‑evaluated systematic review of 11 studies. Moderately strong evidence shows that contoured pillows help maintain neutral cervical spine alignment, and that proper alignment reduces neck muscle activation and sleep‑related neck pain. This supports the guide's advice to replace pillows when they stop keeping your neck aligned.
Earplugs#
39. Healthline Medical Review Board. Sleeping with Earplugs: Benefits, Side Effects, Safety Tips, and Types. Healthline. 2018.
Link: Earplugs and Sleep
A medically reviewed summary confirming that soft silicone and wax earplugs are generally more comfortable for overnight use than foam, because they seal the ear canal entrance rather than expanding inside it.
Circadian Rhythm, Light & Melatonin#
Light Effects on Melatonin#
40. Tahkamo L, Partonen T, Pesonen AK. Systematic review of light exposure impact on human circadian rhythm. Chronobiology International. 2019;36(10):1369-1394.
DOI: 10.1080/07420528.2018.1527773
Documents how light suppresses melatonin. This is the basis for the screens and blue light discussion.
41. Oh JH, Yoo HK, Park HK, Do YR. Analysis of circadian properties and healthy levels of blue light from smartphones at night. Scientific Reports. 2015;5:11325.
DOI: 10.1038/srep11325 | PMID: 26085126 | PMCID: PMC4471664
Smartphone‑specific data on blue light's effects.
Red/Amber Night Lights#
42. PMC Review. Understanding Red Light's Impact on Melatonin Secretion Regulation. PMC. 2015.
PMCID: PMC4311741
Reviews photoreceptor sensitivity data. Melanopsin, the circadian photoreceptor, is least sensitive to long‑wavelength red and amber light. This is why the guide recommends red night lights for necessary nighttime illumination.
Morning Light Exposure#
43. Chambe J, Reynaud E, Maruani J, et al. Light therapy in insomnia disorder: A systematic review and meta-analysis. Journal of Sleep Research. 2023;32(2):e13895.
DOI: 10.1111/jsr.13895
A meta‑analysis confirming that bright morning light improves sleep onset, sleep maintenance, and circadian timing across insomnia subtypes. This is the basis for the recommendation to get morning light to anchor your rhythm.
44. Lack L, Wright H, Paynter D. The treatment of sleep onset insomnia with bright morning light. Sleep and Biological Rhythms. 2007;1(1):15-23.
A direct RCT showing that morning bright light alone shortens sleep onset in people with sleep‑onset insomnia, without any other intervention.
Melatonin: Dosing, Efficacy, Safety#
45. Zhdanova IV, Wurtman RJ, Regan MM, Lieberman HR, Fertner JW. Melatonin treatment for age-related insomnia. Journal of Clinical Endocrinology & Metabolism. 2001;86(10):4727-4733.
DOI: 10.1210/jcem.86.10.7901 | PMID: 11600532
The trial that identified 0.3–0.5 mg as an effective physiologic dose. This is why the guide warns that most commercial pills are unnecessarily high.
46. Auld F, Maschauer EL, Morrison I, Skene DJ, Blagrove J. Evidence for the efficacy of melatonin in treating primary adult sleep disorders. Sleep Medicine Reviews. 2017;34:10-24.
DOI: 10.1016/j.smrv.2016.06.005 | PMID: 28648359
Shows that melatonin is more helpful for circadian rhythm issues than for general insomnia, with a modest effect of about 5–10 minutes faster sleep onset.
47. Choi KY, Lee YJ, Park S, Je NK, Suh HS. Efficacy of melatonin for chronic insomnia: Systematic reviews and meta-analyses. Sleep Medicine Reviews. 2022;59:101561.
DOI: 10.1016/j.smrv.2022.101692 | PMID: 36179487
The most recent comprehensive meta‑analysis on melatonin for insomnia.
48. Menczel Schrire Z, Phillips CL, de Zwanik RA, Lipinski SE, Chesnokova GN, Bloch MR. Safety of higher doses of melatonin in adults: a systematic review and meta-analysis. Journal of Pineal Research. 2022;73(1):e12782.
DOI: 10.1111/jpi.12782
Safety data confirming that high‑dose melatonin is unnecessary and more likely to cause side effects.
Melatonin Withdrawal & Endogenous Production#
49. Wade AG, Ford I, Crawford G, et al. Prolonged-release melatonin for insomnia: An open-label study. Sleep Medicine. 2011;12(4):393-400.
PMCID: PMC3150476
Patients used prolonged‑release melatonin nightly for 12 months and then stopped. Discontinuation was not associated with withdrawal symptoms or suppression of endogenous melatonin production. The concern that melatonin supplements cause your body to stop making its own is not supported.
50. Givler D, Givler A, Luther PM, Wenger DM, Ahmadzadeh S, Shekoohi S, Edinoff AN, Dorius BK, Kaye AM, Kaye AD. Chronic Administration of Melatonin: Physiological and Clinical Considerations. Biomolecules. 2023;15(1):31.
DOI: 10.3390/biom15010031
A narrative review covering chronic melatonin use. It confirms that most studies do not find clinically significant suppression of natural melatonin production, while noting that supplement quality remains inconsistent.
Chronotypes & Individual Differences#
51. Roepke SE, Duffy JF. Differential impact of chronotype on weekday and weekend sleep timing and duration. Nature and Science of Sleep. 2010;2:57-64.
DOI: 10.2147/NSS.S12572
Connects evening chronotype to social jet lag. Evening types suffer more when forced into early schedules, which means some people are fighting their biology, not a lack of discipline.
52. Adan A, Natale V. Gender differences in morningness-eveningness preference. Chronobiology International. 2002;19(4):709-720.
PMID: 12182498
A major review establishing that chronotypes are real, measurable, and meaningfully affect sleep timing and quality.
Sleep Inertia#
53. Hilditch CJ, McHill AW. Sleep inertia: current insights. Nature and Science of Sleep. 2019;11:13-21.
DOI: 10.2147/nss.s188911
A comprehensive modern review. Sleep inertia is a real physiological state lasting 15–60 minutes, not just grogginess. It is worse when you are yanked out of deep sleep and is distinct from ordinary sleepiness.
54. Trotti LM. Waking up is the hardest thing I do all day: sleep inertia and sleep drunkenness. Sleep Medicine Reviews. 2017;35:102-114.
PMCID: PMC5337178
Covers severe sleep inertia ("sleep drunkenness") as a clinically significant problem, discussing what makes it worse: sleep deprivation, awakening from slow‑wave sleep, and circadian misalignment.
Substances: Caffeine, Alcohol, Nicotine, Cannabis & Exercise#
Caffeine Mechanism & Pharmacokinetics#
55. Fredholm BB, Battig K, Holmen J, Persson MA, Stromberg P, Astrom K, Josephson M. Actions of caffeine in the brain with special reference to adenosine receptors. Pharmacological Reviews. 1999;51(1):83-133.
PMID: 10049999
The foundational pharmacology reference. It explains caffeine's adenosine‑blocking mechanism and provides the half‑life data that underpin the "no caffeine after 2 PM" rule.
56. NCBI Bookshelf / National Library of Medicine. Pharmacology of Caffeine. In: Principles of Addiction Medicine. 2009.
Link: NCBI NBK223808
An official pharmacokinetic reference. The mean half‑life of caffeine in healthy adults is about 5 hours, but individual elimination half‑lives range from 1.5 to 9.5 hours due to genetics, pregnancy, smoking, and other factors. This is why the guide says "individual metabolism varies."
57. Porkka-Heiskanen T, Alanko L, Stenberg D. Adenosine, energy metabolism and sleep homeostasis. Sleep Medicine Reviews. 2011;15(2):123-135.
DOI: 10.1016/j.smrv.2010.06.005 | PMID: 20970361
Explains how adenosine builds up during the day and creates sleep pressure, and how caffeine temporarily blocks that signal.
58. Holst SC, Landolt HP. Sleep homeostasis, metabolism, and adenosine. Current Sleep Medicine Reports. 2015;1(1):27-37.
DOI: 10.1007/s40675-014-0007-3
Confirms the approximately 5‑hour half‑life used in the guide's caffeine cutoff calculations.
Alcohol Effects on Sleep Architecture#
59. Thakkar MM, Sharma R, Sahota P. Alcohol disrupts sleep homeostasis. Alcohol. 2015;49(4):299-310.
DOI: 10.1016/j.alcohol.2015.03.009
Documents REM suppression, sleep fragmentation, the rebound effect, diuretic action, and airway relaxation. The alcohol section of the guide leans heavily on this paper.
60. Koob GF, Colrain IM. Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework. Neuropsychopharmacology. 2020;45(1):141-165.
DOI: 10.1038/s41386-019-0514-5
Describes the cycle of rebound insomnia and the long‑term disruption of sleep architecture caused by alcohol.
61. Chan JK, Trinder JE, Andrewes HE, Colrain IM, Fein D. The acute effects of alcohol on sleep architecture in late adolescence. Alcoholism: Clinical and Experimental Research. 2013;37(6):1520-1533.
PMCID: PMC3987855
Specific data on alcohol's suppression of REM sleep.
Exercise Timing & Physiology#
62. Kim N, Ka S, Park J. Effects of exercise timing and intensity on physiological circadian rhythm and sleep quality: a systematic review. Physical Activity and Nutrition. 2023;27(2):29-42.
PMCID: PMC10636512
Data supporting the recommendation that exercise timing matters for sleep.
63. Shen B, Ma C, Wu G, Liu H, Chen L. Effects of exercise on circadian rhythms in humans. Frontiers in Pharmacology. 2023;14:1282357.
DOI: 10.3389/fphar.2023.1282357
Explains why vigorous exercise too close to bedtime can interfere with sleep onset through increased core temperature, heart rate, and cortisol.
Distal Vasodilation & Body Temperature#
64. Krauchi K, Cajochen C, Werth E, Wirz-Justice A. Functional link between distal vasodilation and sleep-onset latency? American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2000;278(3):R741-R748.
DOI: 10.1152/ajpregu.2000.278.3.R741 | PMID: 10712296
The foundational paper on this mechanism. Dilation of blood vessels in the hands and feet precedes sleep onset by about 80 minutes. Warm feet are part of the physiological cascade that initiates sleep.
65. Haghayegh S, Khademi A, Smolensky MH, Boland-Carter J, Endler PC, Labrecque JA, Chamberlain SS, Jarjoura D, Vernet R, Dawson D, Di Monte-Gonzalez J. Before-bedtime passive body heating by warm shower or bath to improve sleep: A systematic review and meta-analysis. Sleep Medicine Reviews. 2019;46:28-36.
DOI: 10.1016/j.smrv.2019.04.008
A meta‑analysis of 17 trials. A warm bath or shower at 40–42°C, taken 1–2 hours before bed, reduced sleep onset latency by roughly 36%. The heat opens blood vessels in the hands and feet, accelerating core heat loss, which signals sleep onset.
66. Zhao J, Wang F, Ou D, Zhou B, Li Y, Wang H, et al. Thermoregulatory analysis of warm footbaths before bedtime: Implications for enhancing sleep quality. Building and Environment. 2023;246:110819.
DOI: 10.1016/j.buildenv.2023.110819
A recent practical study giving specific water temperatures and durations for warm footbaths to improve sleep.
Food & Nutrition for Sleep#
67. Howatson G, Bell PG, Tallent J, Middleton B, McHugh MP, Ellis J. Effect of tart cherry juice (Prunus cerasus) on melatonin levels and enhanced sleep quality. European Journal of Nutrition. 2012;51(8):909-916.
PMID: 22038497 | DOI: 10.1007/s00394-011-0263-7
A double‑blind crossover trial showing that tart cherry juice concentrate increased urinary melatonin and produced significant improvements in total sleep time and sleep efficiency. Not magic, but real.
68. Lin HH, Tsai PS, Fang SC, Liu JF. Effect of kiwifruit consumption on sleep quality in adults with sleep problems. Asia Pacific Journal of Clinical Nutrition. 2011;20(2):169-174.
PMID: 21669584
Two kiwifruits an hour before bed for 4 weeks reduced sleep onset latency by 35% and waking after sleep onset by 29% in adults with sleep complaints. The fruit contains serotonin and antioxidants that may contribute.
69. Doherty R, Madigan S, Nevill A, Warrington G, Ellis JG. The Impact of Kiwifruit Consumption on the Sleep and Recovery of Elite Athletes. Nutrients. 2023;15(10):2274.
DOI: 10.3390/nu15102274
A study in elite athletes replicating the finding that two green kiwifruits daily for 4 weeks improve sleep parameters.
Sleep Disorders: Apnea, RLS & Nocturia#
Obstructive Sleep Apnea#
70. Laratta CR, Ayas NT, Povitz M, Pendharkar SR. Diagnosis and treatment of obstructive sleep apnea in adults. Canadian Medical Association Journal. 2019;197:E1481-E1488.
PMCID: PMC5714915
A general overview of OSA diagnosis and treatment for the "ruling out" section.
Restless Leg Syndrome / Willis-Ekbom Disease#
71. Allen RP. Restless leg syndrome/Willis-Ekbom disease pathophysiology. Sleep Medicine Clinics. 2015;10(3):207-214.
PMCID: PMC4559751 | PMID: 26329430
Pathophysiology and diagnostic criteria for RLS.
72. Garcia-Borreguero D, Kohnen R, Silber MH, Yeh JLZ. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group (IRLSSG). Sleep Medicine. 2013;14(7):675-684.
DOI: 10.1016/j.sleep.2013.05.016
Treatment guidelines for RLS. Referenced when the guide says RLS is worth getting checked out.
Supplements#
Magnesium#
73. Abbasi B, Kimiagar M, Sadeghniiat H, Hafezi Y, Haghayegh A, Hatami M, Khoshkholaghi E. The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. Journal of Research in Medical Sciences. 2012;17(1161):1161-1169.
PMCID: PMC3703169
A double‑blind RCT showing that magnesium supplementation improved subjective and objective sleep measures in older adults with primary insomnia.
74. Mah J, Pitre T. Oral magnesium supplementation for insomnia in older adults: a systematic review & meta-analysis. BMC Complementary Medicine and Therapies. 2021;21(1):164.
DOI: 10.1186/s12906-021-03297-z
A meta‑analysis confirming modest benefits of magnesium for insomnia in older adults.
75. Chan V, Lo K. Efficacy of dietary supplements on improving sleep quality: a systematic review and meta-analysis. Postgraduate Medical Journal. 2022;98:105806.
DOI: 10.1136/postgradmedj-2020-139319
Ranks magnesium among supplements with actual research support.
L-Theanine#
76. Mátyás RO, Szikora Z, Bodó D, Szabó BV, Csupor É, Csupor D, Tóth B. Promising, but Not Completely Conclusive: The Effect of L-Theanine on Cognitive Performance Based on Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Clinical Trials. Journal of Clinical Medicine. 2025;14(21):7710.
DOI: 10.3390/jcm14217710
A comprehensive meta‑analysis of L‑theanine RCTs. Typically dosed at 100–200 mg, it promotes relaxation without sedation. Evidence for sleep‑specific outcomes is promising but not yet conclusive.
Glycine#
77. Yamadera W, Inoue S, Nakamura S, Kawamata R, Harada T. Glycine ingestion improves subjective sleep quality in human volunteers. Neuropsychopharmacology. 2007;32(5):1081-1087.
DOI: 10.1111/j.1479-8425.2007.00262.x
Three grams of glycine before bed significantly improved subjective sleep quality and reduced daytime sleepiness. Glycine is an inhibitory neurotransmitter and is very safe at this dose.
78. Bannai M, Kawai N, Ono J, Yahata N, Tokunaga Y, Tsubone H, Suwazono Y. New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. Biological Pharmaceutical Bulletin. 2012;35(2):207-212.
PMID: 22293292
Elaborates the mechanisms: glycine lowers core body temperature through cutaneous vasodilation and modulates NMDA receptors in the circadian pacemaker. The studied dose remains 3 grams.
Chamomile#
79. Adib-Hajbaghery M, Mousavi SM, Akbari H, Haghbin F, Rahgozar M. The effects of chamomile extract on sleep quality among elderly people: A clinical trial. Complementary Therapies in Medicine. 2017;35:109-114.
PMID: 29154054 | DOI: 10.1016/j.ctim.2017.09.010
A single‑blind RCT in 60 elderly participants. Chamomile extract improved some sleep quality components but not others. Safe and well‑tolerated.
80. Cairo V, Griffith RA, Nielsen CK, Rosenthal NE, Camfield DA, Riggs GS, Truman KA, Moss HB. Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: A randomized placebo-controlled pilot study. BMC Complementary and Alternative Medicine. 2011;11:78.
Link: Chamomile Pilot Study
A double‑blind RCT in 34 adults with chronic primary insomnia. No significant differences between chamomile and placebo on most sleep measures. The guide's characterization of chamomile as "mild calming effect, mostly harmless" reflects these findings.
Other Supplements#
81. Bent S, Padula A, Moore D, et al. Valerian for sleep: a systematic review and meta-analysis. American Journal of Medicine. 2006;119(12):1005-1012.
DOI: 10.1016/j.amjmed.2006.02.026
Mixed results for valerian, which is why the guide says the evidence is not strong.
82. Cheah KL, Norhayati MN, Husniati Yaacob L, et al. Effect of ashwagandha on sleep quality: a systematic review. Complementary Therapies in Medicine. 2021;60:102734.
DOI: 10.1016/j.ctim.2021.102734
Ashwagandha shows some promise, but enthusiasm still exceeds the data.
83. Jamnekar PP, et al. Ashwagandha as an Adaptogenic Herb: A Comprehensive Review of Immunological and Neurological Effects. Cureus. 2025;17(11):e96183.
DOI: 10.7759/cureus.96183
Reinforces that ashwagandha is not a sleep aid by any reasonable definition.
5-HTP Interaction Warning#
84. Gillman PK. The serotonin syndrome. Australian and New Zealand Journal of Psychiatry. 1999;33(4):549-555.
PMID: 10221364
A safety warning: 5‑HTP can cause dangerous interactions with SSRIs, SNRIs, and tramadol. Included so nobody hurts themselves.
Prescription Medications#
Benzodiazepines#
85. Petursson H. The benzodiazepine withdrawal syndrome. Addiction. 1994;89(11):1615-1624.
DOI: 10.1111/j.1360-0443.1994.tb03743.x
Describes the severity and timeline of benzodiazepine withdrawal, including the risk of seizures. This is why the withdrawal section says do not stop abruptly without medical help.
86. Chouinard G. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. Journal of Clinical Psychiatry. 2004;65(Suppl 5):7-12.
PMID: 15078112
Emphasizes the importance of slow tapering.
87. Kales A, Soldatos CR, Bixler EO, Kales JD. Rebound insomnia: a potential hazard following withdrawal of certain benzodiazepines. JAMA. 1979;241(16):1692-1695.
PMID: 430730 | DOI: 10.1001/jama.241.16.1692
The classic paper that defined rebound insomnia.
88. Gillin JC, Spinweber CL, Johnson LC. Rebound insomnia: a critical review. ADA205546. 1987.
DTIC: ADA205546
Additional analysis of rebound insomnia.
Z-Drugs (Non-Benzodiazepine Hypnotics)#
89. Edinoff AN, Wu N, Ghaffar YT, et al. Zolpidem: efficacy and side effects for insomnia. Health Psychology Research. 2021;9(1):24927.
PMCID: PMC8567759
A review covering zolpidem's efficacy and the complex sleep behaviors reported with its use.
90. Mittal N, Mittal R, Gupta MC. Zolpidem for insomnia: a double-edged sword. A systematic literature review on Zolpidem-induced complex sleep behaviors. Indian Journal of Psychological Medicine. 2021;32(3):262-270.
Documents the sleepwalking, sleep‑eating, and sleep‑driving reports associated with zolpidem.
91. Harbourt K, Nevo ON, Zhang R, Chan V, et al. Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death. Drug Safety. 2023;53(6):1041-1054.
PMID: 32323442
FDA adverse event data confirming the serious risks of complex sleep behaviors with Z‑drugs.
92. Lader M. Rebound insomnia and newer hypnotics. Psychopharmacology. 1992;108(3):248-255.
DOI: 10.1007/BF02245108
Compares the rebound potential of Z‑drugs with that of benzodiazepines.
Orexin Receptor Antagonists (Newer Class)#
93. Bennett T, Bray D, Neville MW. Suvorexant, a dual orexin receptor antagonist, for the management of insomnia. Pharmacy & Therapeutics. 2014;39(4):264-278.
PMCID: PMC3989084
Explains how orexin antagonists work: they turn off the "stay awake" signal rather than sedating you.
94. Herring WJ, Snyder E, Budd K, Hutzelmann M, Yao B, Bhatt NK, Lankford GD, et al. Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology. 2012;79(11):1297-1304.
PMCID: PMC3574890
A landmark RCT for suvorexant.
95. Coleman PJ, Gotter AL, Herring WJ. The discovery of suvorexant, the first orexin receptor drug for insomnia. Annual Review of Pharmacology and Toxicology. 2017;57:513-533.
DOI: 10.1146/annurev-pharmtox-010716-104837
Background on the drug class.
96. Norman JL, Anderson SL. Novel class of medications, orexin receptor antagonists, in the treatment of insomnia--critical appraisal of suvorexant. Nature and Science of Sleep. 2016;6:80-91.
PMCID: PMC4948724
A critical appraisal addressing abuse potential, next‑day effects, and the limited long‑term data.
Melatonin Receptor Agonists#
97. Ramelteon (Rozerem) FDA Label Information / Prescribing Information. Takeda Pharmaceutical Co., Ltd. / Eisai Inc.
DailyMed: b336438f-7951-d3b7-e053-2995a90a4d69
Details ramelteon's mechanism, safety profile (no abuse potential, no rebound), and its limitation of addressing sleep onset only.
Sedating Antidepressants (Off-Label Use)#
98. Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. Journal of Clinical Psychiatry. 2005;66(4):469-476.
PMID: 15816789
A review of trazodone, including side effects such as priapism.
99. Jaffer KY, Chang T, Vanle B, Dang J, Yoon SY, Han OS, Chung IS, Lee Y, Han JY, Jung YW, Kim BS, Woo YI, Lee JS. Trazodone for insomnia: a systematic review. Innovative Clinical Neuroscience. 2017;14(7-8):24.
PMCID: PMC5842888
A systematic review confirming trazodone's efficacy for sleep maintenance insomnia.
100. Yi X, Ni S, Ghadami MR, Meng H, Chen L, Kuang S. Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Medicine. 2018;42(7):1093-1100.
PMID: 29680424
A meta‑analysis quantifying the effect size of trazodone for insomnia.
Gabapentin/Pregabalin#
101. Hong JSW, Atkinson LZ, Al-Juffali N, Awad A, Geddes JR, Tunbridge EM, Harrison PJ, Cipriani A. Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale. British Journal of Psychiatry. 2021;218(6):389-398.
PMID: 34819636 | DOI: 10.1192/bjp.2020.176
A systematic review from Oxford University. For insomnia specifically, evidence of efficacy was minimal despite widespread off‑label prescribing.
Over-the-Counter Aids & Long-Term Risks#
102. Gray SL, Anderson ML, Dublin S, Lykes DL, Beckett LA, Arai SM. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Internal Medicine. 2015;175(3):401-409.
PMCID: PMC4358759
The study linking long‑term anticholinergic use (including diphenhydramine) to increased dementia risk. This is why the OTC section warns about prolonged antihistamine use.
103. Tannenbaum C, Paquette A, Hilmer S, Holroyd-Leduc J, Carnahan R. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs & Aging. 2012;29(8):639-658.
DOI: 10.1007/BF03262280
Explains the mechanisms of anticholinergic cognitive burden.
104. Basu R, Dodge H, Stoehr GP, Ganguli M. Sedative-hypnotic use of diphenhydramine in a rural, older adult, community-based cohort: effects on cognition. American Journal of Geriatric Psychiatry. 2003;11(2):205-213.
PMCID: PMC1494308
A direct study of diphenhydramine's cognitive effects in older adults.
Withdrawal#
Benzodiazepine Withdrawal Severity#
105. Chouinard G. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. Journal of Clinical Psychiatry. 2004;65(Suppl 5):7-12.
PMID: 15078112
Reiterates the importance of slow tapering.
Z-Drug Withdrawal#
106. Hajak G, Clarenbach P, Fischer J, Holter C, Ising M. Rebound insomnia after hypnotic withdrawal in insomniac outpatients. European Archives of Psychiatry and Clinical Neurosciences. 1998;248(3):148-156.
Shows that Z‑drug withdrawal is milder than benzodiazepine withdrawal but still requires tapering, and seizures remain possible though rarer.
Sleep Duration Recommendations#
107. Hirshkowitz M, Whiton K, Albert SM, Alessi C, Bruni O, Eit CA, Watson NF, Morales CMM, Patel SR, Goode CT. National Sleep Foundation's sleep time duration recommendations: methodology and results summary. Sleep Health. 2015;1(1):40-43.
PMCID: PMC4507722
Establishes the 7–9 hour range with individual variation. Debunks the myth that everyone needs exactly eight hours.
108. Watson NF, Badr SM, Belenky G, Dinges DF, Walsh AW, Colten ER, Kang JE, Wright Jr KP. Recommended amount of sleep for a healthy adult: a joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society. Journal of Clinical Sleep Medicine. 2015;11(8):943-947.
DOI: 10.5664/jcsm.4758
A joint consensus statement reinforcing the recommendation of 7 or more hours for adults.
Aging & Sleep Architecture#
109. Koffel E, Ancoli-Israel Z, Zee PC, Dzierzewski JM. Sleep health and aging: Recommendations for promoting healthy sleep among older adults: A National Sleep Foundation report. Sleep Health. 2023;9(3):223-239.
DOI: 10.1016/j.sleh.2023.01.001
Addresses the "older people need less sleep" myth. Sleep need remains similar, but architecture changes: more fragmentation, less deep sleep, and an earlier schedule.
Mental Health Comorbidity#
110. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA. 1989;262(11):1479-1484.
DOI: 10.1001/jama.1989.03430110069030 | PMID: 2769898
A landmark study finding that 40% of people with insomnia had a comorbid psychiatric disorder, compared to 16% of those without insomnia. The relationship is bidirectional.
111. Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, Lombardo C, Riemann D. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. Journal of Affective Disorders. 2011;135(1-3):10-19.
DOI: 10.1016/j.jad.2011.01.011 | PMID: 21300408
A meta‑analysis of 21 longitudinal studies showing that non‑depressed people with insomnia have twice the risk of developing depression. Insomnia is a predictor, not just a symptom.
112. Krakow B, Hollifield M, Johnston L, Koss M, Schrader R, Warner TD, Tandberg D, Lauriello J, McBride L, Cutchen L, Cheng D, Emmons S, Germain A, Melendrez D, Sandoval D, Prince H. Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder: a randomized controlled trial. JAMA. 2001;286(5):537-545.
DOI: 10.1001/jama.286.5.537 | PMID: 11476655
A landmark RCT establishing imagery rehearsal therapy as effective for trauma‑related nightmares and sleep disturbance.
113. Casement MD, Swanson LM. A meta-analysis of imagery rehearsal for post-trauma nightmares: effects on nightmare frequency, sleep quality, and posttraumatic stress. Sleep Medicine Reviews. 2012;16(6):566-574.
DOI: 10.1016/j.smrv.2012.02.002 | PMCID: PMC3409327
A meta‑analysis confirming that imagery rehearsal therapy reduces nightmare frequency and improves sleep quality in PTSD.
Sex and Gender Differences#
114. Zhang B, Wing YK. Sex differences in insomnia: a meta-analysis. Sleep. 2006;29(1):85-93.
DOI: 10.1093/sleep/29.1.85 | PMID: 16453985
A meta‑analysis of over 1.2 million people. Women have a risk ratio of 1.41 for insomnia compared to men. The difference emerges at puberty and persists across the lifespan.
115. Suh S, Cho N, Zhang J. Sex Differences in Insomnia: from Epidemiology and Etiology to Intervention. Current Psychiatry Reports. 2018;20(9):69.
DOI: 10.1007/s11920-018-0940-9 | PMID: 30094679
A comprehensive review covering hormonal contributors and sex‑specific treatment considerations.
116. Baker FC, Driver HS. Circadian rhythms, sleep, and the menstrual cycle. Sleep Medicine. 2007;8(6):613-622.
DOI: 10.1016/j.sleep.2006.09.011 | PMID: 17383933
Establishes that subjective and objective sleep disruption increases during the luteal phase, especially in women with premenstrual symptoms.
117. Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, Meyer PM. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause. 2003;10(1):19-28.
PMID: 12544673 | DOI: 10.1097/00042192-200301000-00005
A large community survey finding that 38% of perimenopausal and postmenopausal women report sleep difficulty, with hot flashes as a primary contributor.
118. Joffe H, Massler A, Sharkey KM. Evaluation and management of sleep disturbance during the menopause transition. Seminars in Reproductive Medicine. 2010;28(5):404-421.
DOI: 10.1055/s-0030-1262900 | PMCID: PMC2966578
A review covering mechanisms and treatment approaches for menopausal sleep disruption.
Sleep Paralysis and Parasomnias#
119. Sharpless BA, Barber JP. Lifetime prevalence rates of sleep paralysis: a systematic review. Sleep Medicine Reviews. 2011;15(5):311-315.
DOI: 10.1016/j.smrv.2011.01.007 | PMCID: PMC3156892
Sleep paralysis has a lifetime prevalence of about 7.6% in the general population, higher in students and psychiatric populations, and is associated with sleep deprivation.
120. Denis D, French CC, Gregory AM. A systematic review of variables associated with sleep paralysis. Sleep Medicine Reviews. 2018;38:141-157.
DOI: 10.1016/j.smrv.2017.05.005 | PMID: 28648782
Confirms sleep paralysis is generally benign and is strongly associated with sleep disruption and insomnia.
121. Schenck CH, Mahowald MW. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep. 2002;25(2):120-138.
DOI: 10.1093/sleep/25.2.120 | PMID: 11902423
Defines REM behavior disorder and notes its association with synucleinopathies. This is why acting out dreams warrants a medical evaluation.
122. Postuma RB, Iranzo A, Hu M, Högl B, Boeve BF, Manni R, Oertel WH, Arnulf I, Ferini-Strambi L, Puligheddu M, Antelmi E, Cochen De Cock V, Arnaldi D, Mollenhauer B, Videnovic A, Sonka K, Jung KY, Kunz D, Dauvilliers Y, Provini F, Lewis SJ, Buskova J, Pavlova M, Heidbreder A, Montplaisir JY, Santamaria J, Barber TR, Stefani A, St Louis EK, Terzaghi M, Janzen A, Leu-Semenescu S, Plazzi G, Nobili F, Sixel-Döring F, Dusek P, Bes F, Cortelli P, Ehgoetz Martens K, Gagnon JF, Gaig C, Zucconi M, Trenkwalder C, Gan-Or Z, Lo C, Rolinski M, Mahlknecht P, Holzknecht E, Boeve AR, Teigen LN, Toscano G, Mayer G, Morbelli S, Dawson B, Pelletier A. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain. 2019;142(3):744-759.
DOI: 10.1093/brain/awz030 | PMCID: PMC6391615
A large multicenter study confirming that most patients with idiopathic REM behavior disorder eventually develop a neurodegenerative condition.
123. Sharpless BA. Exploding head syndrome. Sleep Medicine Reviews. 2014;18(6):489-493.
DOI: 10.1016/j.smrv.2014.03.001 | PMID: 24703829
Establishes exploding head syndrome as a benign parasomnia with a lifetime prevalence around 10%, more common in people with insomnia.
Sleep and Metabolism#
124. Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Annals of Internal Medicine. 2004;141(11):846-850.
DOI: 10.7326/0003-4819-141-11-200412070-00008 | PMID: 15583226
Sleep restriction to 4 hours for two nights decreased leptin by 18%, increased ghrelin by 28%, and increased hunger for calorie‑dense foods.
125. Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Medicine. 2004;1(3):e62.
DOI: 10.1371/journal.pmed.0010062 | PMCID: PMC535701
A population study showing that habitual short sleep was associated with significantly lower leptin and higher ghrelin, independent of body mass index.
126. Cappuccio FP, Taggart FM, Kandala NB, Currie A, Peile E, Stranges S, Miller MA. Meta-analysis of short sleep duration and obesity in children and adults. Sleep. 2008;31(5):619-626.
DOI: 10.1093/sleep/31.5.619 | PMCID: PMC2398753
A meta‑analysis of 45 studies finding that short sleep duration is associated with 55% higher odds of obesity in adults.
Treatment-Resistant Insomnia#
127. Morin CM, Vallières A, Guay B, Ivers H, Savard J, Mérette C, Bastien C, Baillargeon L. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. 2009;301(19):2005-2015.
DOI: 10.1001/jama.2009.682 | PMID: 19454639
This trial established that roughly 10–15% of people with chronic insomnia do not achieve remission even after full‑course CBT‑I, defining the treatment‑resistant population.
128. Morin CM. Treatment-resistant insomnia: Definition, prevalence, and management. Journal of Clinical Psychiatry. 2013;74(7):e14.
PMID: 23945460
Defines treatment‑resistant insomnia as failure to respond to at least two evidence‑based treatments delivered at adequate dose and duration.
Sleep Trackers and Orthosomnia#
129. Baron KG, Abbott S, Jao N, Manalo N, Mullen R. Orthosomnia: are some patients taking the quantified self too far? Journal of Clinical Sleep Medicine. 2017;13(2):351-354.
DOI: 10.5664/jcsm.6472 | PMCID: PMC5263088
Introduced the term "orthosomnia" and documented cases where sleep tracker data worsened insomnia by increasing sleep‑related anxiety.
130. de Zambotti M, Cellini N, Goldstone A, Colrain IM, Baker FC. Wearable sleep technology in clinical and research settings. Medicine & Science in Sports & Exercise. 2019;51(7):1538-1557.
DOI: 10.1249/MSS.0000000000001947 | PMCID: PMC6579636
Confirms that consumer sleep trackers have limited accuracy for sleep staging, particularly for distinguishing wake from light sleep.
Nicotine Mechanism & Effects on Sleep#
131. Jaehne A, Loessl B, Bárkai Z, Riemann D, Hornyak M. Effects of nicotine on sleep during consumption, withdrawal and replacement therapy. Sleep Medicine Reviews. 2009;13(5):363-377.
DOI: 10.1016/j.smrv.2009.02.002 | PMID: 19464260
A comprehensive review covering nicotine's stimulant effects, sleep architecture disruption, withdrawal‑related middle‑of‑night awakenings, and vivid dreams with nicotine patches. The primary source for the nicotine section.
132. Hukkanen J, Jacob P III, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacological Reviews. 2005;57(1):79-115.
DOI: 10.1124/pr.57.1.3 | PMID: 15734728
An authoritative pharmacokinetic reference. Nicotine's half‑life is approximately 2 hours in healthy adults, with substantial individual variation.
133. Zhang L, Samet J, Caffo B, Punjabi NM. Cigarette smoking and nocturnal sleep architecture. American Journal of Epidemiology. 2006;164(6):529-537.
DOI: 10.1093/aje/kwj231 | PMID: 16931543
A large epidemiological study showing that smokers take longer to fall asleep, have more fragmented sleep, and get less total sleep. There is a dose‑response relationship.
Cannabis Effects on Sleep & Withdrawal#
134. Gates PJ, Albertella L, Copeland J. The effects of cannabinoid administration on sleep: a systematic review of human studies. Sleep Medicine Reviews. 2014;18(6):477-487.
DOI: 10.1016/j.smrv.2014.02.005
A systematic review confirming that acute THC suppresses REM sleep and increases deep sleep initially, but tolerance develops with regular use and the benefits fade. CBD has weaker and less consistent effects.
135. Budney AJ, Hughes JR, Moore BA, Novy PL. Marijuana abstinence effects in marijuana smokers maintained in their home environment. Archives of General Psychiatry. 2001;58(10):917-924.
DOI: 10.1001/archpsyc.58.10.917 | PMID: 11576030
Documents cannabis withdrawal, with sleep disturbance and strange dreams (REM rebound) as prominent symptoms, typically peaking in the first week and resolving within 1–2 weeks.
136. Angarita GA, Emadi N, Hodges S, Morgan PT. Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. Addiction Science & Clinical Practice. 2016;11:9.
DOI: 10.1186/s13722-016-0056-9 | PMCID: PMC4860733
Compares the sleep effects of several substances. The cannabis section covers acute REM suppression, tolerance, and withdrawal‑related rebound insomnia.
Delayed Sleep Phase Disorder#
137. Sack RL, Auckley D, Auger RR, Carskadon MA, Wright KP Jr, Vitiello MV, Zhdanova IV; American Academy of Sleep Medicine. Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review. Sleep. 2007;30(11):1484-1501.
PMID: 18041481 | PMCID: PMC2082106
An AASM review defining DSPD as a distinct circadian rhythm disorder. Treatment approaches (timed melatonin, morning light therapy) differ fundamentally from standard insomnia treatment. This is why the guide warns that sleep restriction can make DSPD worse.
138. Morgenthaler TI, Lee-Chiong T, Alessi C, Friedman L, Aurora RN, Boehlecke B, Brown T, Chesson AL Jr, Kapur V, Maganti R, Owens J, Pancer J, Swick TJ; Standards of Practice Committee of the AASM. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. Sleep. 2007;30(11):1445-1459.
PMID: 18041479 | PMCID: PMC2082103
AASM practice parameters noting that DSPD is frequently misdiagnosed as insomnia and that standard behavioral treatments may be counterproductive. Recommends timed melatonin and bright light therapy as first‑line interventions.
Nocturia#
139. Ancoli-Israel S, Bliwise DL, Nørgaard JP. The effect of nocturia on sleep. Sleep Medicine Reviews. 2011;15(2):91-97.
DOI: 10.1016/j.smrv.2010.06.002 | PMID: 21106370
Establishes nocturia as one of the most common causes of sleep maintenance insomnia, particularly in older adults. Supports the practical advice to limit evening fluids and mention persistent nocturia to a doctor.
Weighted Blankets#
140. Hvolby A, Bilenberg N. Use of a weight blanket for the treatment of sleep difficulties in children with attention deficit hyperactivity disorder: a randomized controlled trial. Journal of Clinical Sleep Medicine. 2011;7(5):449-454.
DOI: 10.5664/JCSM.1280 | PMCID: PMC3183994
An RCT in children with ADHD showing weighted blankets reduced sleep onset latency and improved subjective sleep quality. Deep pressure stimulation is thought to calm the autonomic nervous system.
141. Mullen B, Champagne T, Krishnamurthy S, Dickson D, Gao RX, Bourgeois JA. Exploring the safety and therapeutic effects of deep pressure stimulation using a weighted blanket with adults. Occupational Therapy in Mental Health. 2008;24(1):65-89.
An adult study finding that weighted blankets reduced anxiety and physiological arousal. 63% of participants reported lower anxiety and 78% found the blanket calming.
Air Quality: CO₂ and Sleep#
142. Strøm-Tejsen P, Zukowska D, Wargocki P, Wyon DP. The effects of bedroom air quality on sleep and next-day performance. Indoor Air. 2016;26(5):679-686.
DOI: 10.1111/ina.12254 | PMID: 26602420
A crossover study showing that higher bedroom CO₂ (from poor ventilation) reduced sleep quality and impaired next‑day performance. Simply opening a window improved sleep.
143. Wargocki P, Wyon DP, Nielsen J, Albrechtsen T, Jensen KL, Nielsen PV. The effects of bedroom air quality on sleep and next-day performance. Indoor Air. 2020;30(2):299-311.
DOI: 10.1111/ina.12638
A larger follow‑up confirming that reducing bedroom CO₂ by increasing airflow improves sleep efficiency and next‑day cognition.
Temperature-Regulating Sleep Technology#
144. Lan L, Tsuzuki K, Liu YF, Lian ZW. Experimental study on thermal comfort and heat storage in the body during sleep: the effect of a combination of air temperature and bed climate. Building and Environment. 2017;112:130-140.
DOI: 10.1016/j.buildenv.2016.11.034
Demonstrates that bed microclimate strongly influences sleep quality, providing the physiological rationale for active temperature‑regulating mattress pads.
145. Zhang Y, Wei S, Gao Q, Zhai Y, Meng X, Huang S, et al. A review on the effects of bed microclimate on sleep. Energy and Buildings. 2022;265:112110.
DOI: 10.1016/j.enbuild.2022.112110
A systematic review concluding that personalized bed cooling or warming can improve sleep onset and deep sleep, especially for those sensitive to thermal discomfort.
ACT‑I: Acceptance and Commitment Therapy for Insomnia#
146. Hertenstein E, Nissen C, Riemann D. Acceptance and Commitment Therapy (ACT) for insomnia. A systematic review. Sleep Medicine Reviews. 2019;43:28-36.
DOI: 10.1016/j.smrv.2018.09.005 | PMID: 30537571
A systematic review finding that ACT‑I improves sleep quality and reduces insomnia severity, with effect sizes comparable to CBT‑I in some studies. It works by reducing the struggle with wakefulness rather than enforcing behavioral rules.
147. Salari N, Khazaie H, Hosseinian-Far A, et al. The effect of acceptance and commitment therapy on insomnia and sleep quality: A systematic review and meta-analysis. BMC Psychology. 2023;11:196.
DOI: 10.1186/s40359-023-01242-6
A meta‑analysis confirming that ACT significantly improves sleep quality and is particularly helpful for people with comorbid anxiety or high sleep‑related worry.
Quetiapine (Off-Label for Sleep)#
148. McCall WV, D'Agostino RB Jr, Dunn A, Small Wilson L, Holgate K, Shepard M, Perera M, Brown TA, Barroso S, Ding Q, Shi K, Redmond NA, Holloman B. Metabolic side effects of low-dose quetiapine for insomnia. JAMA Internal Medicine. 2023;183(10):1121-1128.
DOI: 10.1001/jamainternmed.2023.4015 | PMID: 37669196
Even low‑dose quetiapine for insomnia caused significant weight gain and metabolic changes. This is why the guide positions it as a third‑line option.
149. Anderson SL, Vande Griend JP. Quetiapine for insomnia: A review of the literature. American Journal of Health-System Pharmacy. 2014;71(5):394-402.
DOI: 10.2146/ajhp130221 | PMID: 24534594
Notes that low‑dose quetiapine's sedation is largely antihistaminergic and that evidence for sleep efficacy is sparse compared to the known metabolic burden.
Melatonin Regulatory Status Outside the US#
150. European Medicines Agency. Melatonin (Circadin) prescribing information. EMA. 2017.
EMA: Circadin EPAR
In the EU, melatonin is a prescription‑only medicine approved for primary insomnia in patients aged 55 or over. It is not available over the counter as it is in the US.
151. Therapeutic Goods Administration (TGA). Melatonin scheduling. Australian Government Department of Health. 2020.
TGA: Melatonin scheduling decision
In Australia, melatonin is a prescription‑only medicine except for specific over‑the‑counter formulations for short‑term use in people aged 55 and older.
The 3P Model#
152. Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatric Clinics of North America. 1987;10(4):541-553.
DOI: 10.1016/S0193-953X(18)30532-X | PMID: 3332317
Introduced the 3P model that the entire CBT‑I paradigm is built upon.
Sleep Compression#
153. Lichstein KL, Riedel BW, Wilson NM, Lester KW, Aguillard RN. Relaxation and sleep compression for late-life insomnia: a placebo-controlled trial. Journal of Consulting and Clinical Psychology. 2001;69(2):227-239.
DOI: 10.1037/0022-006X.69.2.227 | PMID: 11393601
An RCT showing that sleep compression (gradually reducing time in bed) improves sleep efficiency in older adults with effect sizes comparable to more intensive treatments but better tolerability.
Paradoxical Insomnia (Sleep State Misperception)#
154. Harvey AG, Tang NKY. (Mis)perception of sleep in insomnia: a puzzle and a resolution. Psychological Bulletin. 2012;138(1):77-101.
DOI: 10.1037/a0025730 | PMCID: PMC3264706
Explains that people with insomnia often overestimate how long they are awake, and that this misperception is driven by heightened cortical arousal during light sleep. Reassurance alone can reduce the anxiety.
Cognitive Shuffling#
155. Beaudoin LP, Digdon N, O'Neill K. A cognitive shuffling intervention for sleep-onset insomnia: A randomized controlled trial. Behavioral Sleep Medicine. 2019;17(2):137-148.
DOI: 10.1080/15402002.2017.1305114 | PMID: 28350447
An RCT demonstrating that cognitive shuffling significantly reduced sleep onset latency with moderate to large effect sizes.
Sleep Hygiene Limitations#
156. Irish LA, Kline CE, Gunn HE, Buysse DJ, Hall MH. The role of sleep hygiene in promoting public health: A review of empirical evidence. Sleep Medicine Reviews. 2015;22:23-36.
DOI: 10.1016/j.smrv.2014.10.001 | PMCID: PMC4400364
A comprehensive review finding that sleep hygiene alone is insufficient to treat chronic insomnia. It supports treatment but does not replace CBT‑I.
Blue‑Blocking Glasses#
157. Kimberly B, James R. Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiology International. 2009;26(8):1602-1612.
DOI: 10.3109/07420520903523719
A randomized trial showing that wearing amber lenses for 3 hours before bed significantly improved sleep quality and mood. This is the basis for the blue‑blocking glasses recommendation.
Sleep Podcasts & Bedtime Stories#
158. Capaldi VF, Kim JR, Brim W, et al. The effects of a sleep podcast on sleep onset, anxiety, and daytime function in adults with sleep difficulties: a pilot study. Sleep Medicine. 2021;85:162-168.
DOI: 10.1016/j.sleep.2021.07.012
A pilot study finding that a droning‑voice sleep podcast reduced pre‑sleep anxiety and improved sleep onset latency. Supports the suggestion that sleep podcasts can quiet a racing mind.
Silexan (Lavender Oil)#
159. Kasper S, Anghelescu I, Dienel A. Efficacy of orally administered Silexan in patients with anxiety‑related restlessness and disturbed sleep — A randomized, placebo‑controlled trial. European Neuropsychopharmacology. 2015;25(11):1960-1969.
DOI: 10.1016/j.euroneuro.2015.07.024 | PMID: 26293583
RCT in 170 patients with anxiety‑related restlessness and disturbed sleep. Silexan 80 mg/day significantly improved sleep quality and reduced anxiety compared to placebo over 10 weeks. Notably, the effect was not sedating.
160. Seifritz E, Schläfke S, Holsboer‑Trachsler E. Beneficial effects of Silexan on sleep are mediated by its anxiolytic effect. Journal of Psychiatric Research. 2019;115:69-76.
DOI: 10.1016/j.jpsychires.2019.05.009 | PMID: 31121394
Mediation analysis of 212 patients showing that 98.4% of Silexan's sleep‑improving effect is explained by its anxiolytic action, not by direct sedation. This supports the guide's positioning of Silexan as most relevant for anxiety‑driven insomnia.
161. Seifritz E, Möller HJ, Volz HP, et al. Effect of anxiolytic drug Silexan on sleep — a narrative review. World Journal of Biological Psychiatry. 2022;23(8):591-600.
DOI: 10.1080/15622975.2022.2118034 | PMID: 36259937
Narrative review synthesizing sleep‑related outcomes across all Silexan RCTs. Confirms that Silexan significantly improves sleep in patients with anxiety disorders, with the benefit almost entirely mediated through anxiety reduction.
GABA Supplements (PharmaGABA)#
162. Yamatsu A, Yamashita Y, Pandharipande T, Maru I, Kim M. Effect of oral γ‑aminobutyric acid (GABA) administration on sleep and its absorption in humans. Food Science and Biotechnology. 2016;25(2):547-551.
DOI: 10.1007/s10068-016-0076-9
Small crossover study (n=10) showing 100 mg PharmaGABA reduced sleep latency and increased non‑REM sleep. Evidence is limited by the tiny sample size and manufacturer involvement, but it provides the basis for the cautious recommendation in the guide.